Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IntegraGen identifies three obesity genes:

This article was originally published in Clinica

Executive Summary

French genomics company IntegraGen reports that it has used its GenomeHIP (genome hybrid identity profiling) technology to identify the narrow location of three genes linked to the early onset of obesity. The discovery, says the firm, could lead to therapeutics and diagnostics strategies for the disease. "The identification of the three narrow loci, which are at least ten times smaller in size than that of regions usually obtained using traditional gene mapping methods demonstrates the power of our technology," says the Paris-based firm's chief scientific officer, Dr Jorg Hager.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT067001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel